UniProt ID | TTC7A_HUMAN | |
---|---|---|
UniProt AC | Q9ULT0 | |
Protein Name | Tetratricopeptide repeat protein 7A {ECO:0000305} | |
Gene Name | TTC7A {ECO:0000312|HGNC:HGNC:19750} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 858 | |
Subcellular Localization | Cytoplasm . Cell membrane . Localizes to the cytosol and is recruited to the plasma membrane following interaction with EFR3 (EFR3A or EFR3B). | |
Protein Description | Component of a complex required to localize phosphatidylinositol 4-kinase (PI4K) to the plasma membrane. [PubMed: 23229899] | |
Protein Sequence | MAAKGAHGSYLKVESELERCRAEGHWDRMPELVRQLQTLSMPGGGGNRRGSPSAAFTFPDTDDFGKLLLAEALLEQCLKENHAKIKDSMPLLEKNEPKMSEAKNYLSSILNHGRLSPQYMCEAMLILGKLHYVEGSYRDAISMYARAGIDDMSMENKPLYQMRLLSEAFVIKGLSLERLPNSIASRFRLTEREEEVITCFERASWIAQVFLQELEKTTNNSTSRHLKGCHPLDYELTYFLEAALQSAYVKNLKKGNIVKGMRELREVLRTVETKATQNFKVMAAKHLAGVLLHSLSEECYWSPLSHPLPEFMGKEESSFATQALRKPHLYEGDNLYCPKDNIEEALLLLLISESMATRDVVLSRVPEQEEDRTVSLQNAAAIYDLLSITLGRRGQYVMLSECLERAMKFAFGEFHLWYQVALSMVACGKSAYAVSLLRECVKLRPSDPTVPLMAAKVCIGSLRWLEEAEHFAMMVISLGEEAGEFLPKGYLALGLTYSLQATDATLKSKQDELHRKALQTLERAQQLAPSDPQVILYVSLQLALVRQISSAMEQLQEALKVRKDDAHALHLLALLFSAQKHHQHALDVVNMAITEHPENFNLMFTKVKLEQVLKGPEEALVTCRQVLRLWQTLYSFSQLGGLEKDGSFGEGLTMKKQSGMHLTLPDAHDADSGSRRASSIAASRLEEAMSELTMPSSVLKQGPMQLWTTLEQIWLQAAELFMEQQHLKEAGFCIQEAAGLFPTSHSVLYMRGRLAEVKGNLEEAKQLYKEALTVNPDGVRIMHSLGLMLSRLGHKSLAQKVLRDAVERQSTCHEAWQGLGEVLQAQGQNEAAVDCFLTALELEASSPVLPFSIIPREL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Ubiquitination | ----MAAKGAHGSYL ----CCCCCCCCCCC | 47.28 | - | |
4 | Ubiquitination | ----MAAKGAHGSYL ----CCCCCCCCCCC | 47.28 | - | |
9 | Phosphorylation | AAKGAHGSYLKVESE CCCCCCCCCCCHHHH | 19.88 | - | |
12 | Ubiquitination | GAHGSYLKVESELER CCCCCCCCHHHHHHH | 35.41 | - | |
51 | Phosphorylation | GGGNRRGSPSAAFTF CCCCCCCCCCCCEEC | 17.55 | 29255136 | |
53 | Phosphorylation | GNRRGSPSAAFTFPD CCCCCCCCCCEECCC | 33.65 | 29255136 | |
57 | Phosphorylation | GSPSAAFTFPDTDDF CCCCCCEECCCCCHH | 29.54 | 30266825 | |
61 | Phosphorylation | AAFTFPDTDDFGKLL CCEECCCCCHHHHHH | 37.39 | 23403867 | |
79 | Ubiquitination | ALLEQCLKENHAKIK HHHHHHHHHCCCCHH | 65.19 | - | |
79 | Ubiquitination | ALLEQCLKENHAKIK HHHHHHHHHCCCCHH | 65.19 | - | |
84 | Ubiquitination | CLKENHAKIKDSMPL HHHHCCCCHHCCCCH | 42.62 | - | |
100 | Phosphorylation | EKNEPKMSEAKNYLS HCCCCCHHHHHHHHH | 40.29 | 24719451 | |
103 | Ubiquitination | EPKMSEAKNYLSSIL CCCHHHHHHHHHHHH | 41.91 | - | |
103 | Ubiquitination | EPKMSEAKNYLSSIL CCCHHHHHHHHHHHH | 41.91 | - | |
105 | Phosphorylation | KMSEAKNYLSSILNH CHHHHHHHHHHHHHC | 13.78 | 24719451 | |
108 | Phosphorylation | EAKNYLSSILNHGRL HHHHHHHHHHHCCCC | 28.62 | 24719451 | |
116 | Phosphorylation | ILNHGRLSPQYMCEA HHHCCCCCHHHHHHH | 14.48 | - | |
157 | Ubiquitination | DDMSMENKPLYQMRL CCCCCCCCCHHHHHH | 24.08 | - | |
157 | Ubiquitination | DDMSMENKPLYQMRL CCCCCCCCCHHHHHH | 24.08 | - | |
160 | Phosphorylation | SMENKPLYQMRLLSE CCCCCCHHHHHHHHH | 14.59 | - | |
172 (in isoform 1) | Ubiquitination | - | 48.80 | 21890473 | |
172 | Ubiquitination | LSEAFVIKGLSLERL HHHHHHHCCCCHHHC | 48.80 | 21890473 | |
175 | Phosphorylation | AFVIKGLSLERLPNS HHHHCCCCHHHCCCC | 36.53 | 29978859 | |
182 | Phosphorylation | SLERLPNSIASRFRL CHHHCCCCHHHCCCC | 20.00 | 23401153 | |
185 | Phosphorylation | RLPNSIASRFRLTER HCCCCHHHCCCCCCC | 30.22 | 30266825 | |
221 | Phosphorylation | LEKTTNNSTSRHLKG HHHHCCCCCCCCCCC | 29.81 | 24719451 | |
259 | Ubiquitination | LKKGNIVKGMRELRE CCCCCHHHHHHHHHH | 43.10 | - | |
259 | Ubiquitination | LKKGNIVKGMRELRE CCCCCHHHHHHHHHH | 43.10 | - | |
274 | Ubiquitination | VLRTVETKATQNFKV HHHHHHCHHCCCHHH | 35.61 | - | |
280 | Ubiquitination | TKATQNFKVMAAKHL CHHCCCHHHHHHHHH | 38.35 | - | |
280 | Ubiquitination | TKATQNFKVMAAKHL CHHCCCHHHHHHHHH | 38.35 | - | |
326 | Ubiquitination | FATQALRKPHLYEGD HHHHHHCCCCCCCCC | 37.32 | - | |
326 | Ubiquitination | FATQALRKPHLYEGD HHHHHHCCCCCCCCC | 37.32 | - | |
389 | Phosphorylation | IYDLLSITLGRRGQY HHHHHHCCCCCCCCE | 21.56 | 24719451 | |
396 | Phosphorylation | TLGRRGQYVMLSECL CCCCCCCEEEHHHHH | 7.22 | - | |
400 | Phosphorylation | RGQYVMLSECLERAM CCCEEEHHHHHHHHH | 14.25 | - | |
418 | Phosphorylation | FGEFHLWYQVALSMV HCCHHHHHHHHHHHH | 10.24 | 27461979 | |
423 | Phosphorylation | LWYQVALSMVACGKS HHHHHHHHHHHCCHH | 11.06 | 27461979 | |
449 | Phosphorylation | KLRPSDPTVPLMAAK HCCCCCCCCHHHHHH | 39.48 | 17322306 | |
461 | Phosphorylation | AAKVCIGSLRWLEEA HHHHHHHHHHHHHHH | 8.54 | 24719451 | |
505 | Phosphorylation | SLQATDATLKSKQDE EEHHHCHHHHHHHHH | 37.21 | 20068231 | |
516 | Ubiquitination | KQDELHRKALQTLER HHHHHHHHHHHHHHH | 42.58 | - | |
516 | Ubiquitination | KQDELHRKALQTLER HHHHHHHHHHHHHHH | 42.58 | - | |
560 (in isoform 1) | Ubiquitination | - | 47.22 | 21890473 | |
560 | Ubiquitination | EQLQEALKVRKDDAH HHHHHHHHCCCCHHH | 47.22 | 21890473 | |
560 | Ubiquitination | EQLQEALKVRKDDAH HHHHHHHHCCCCHHH | 47.22 | 21906983 | |
647 | Phosphorylation | GGLEKDGSFGEGLTM CCCCCCCCCCCCCCC | 39.96 | 25159151 | |
653 | Phosphorylation | GSFGEGLTMKKQSGM CCCCCCCCCCCCCCC | 37.49 | 23403867 | |
655 (in isoform 1) | Ubiquitination | - | 42.29 | 21890473 | |
655 | Ubiquitination | FGEGLTMKKQSGMHL CCCCCCCCCCCCCEE | 42.29 | 21906983 | |
656 | Ubiquitination | GEGLTMKKQSGMHLT CCCCCCCCCCCCEEE | 38.58 | - | |
658 | Phosphorylation | GLTMKKQSGMHLTLP CCCCCCCCCCEEECC | 47.14 | 23312004 | |
663 | Phosphorylation | KQSGMHLTLPDAHDA CCCCCEEECCCCCCC | 22.90 | 23312004 | |
672 | Phosphorylation | PDAHDADSGSRRASS CCCCCCCCCCHHHHH | 40.15 | 25849741 | |
674 | Phosphorylation | AHDADSGSRRASSIA CCCCCCCCHHHHHHH | 23.65 | 28857561 | |
678 | Phosphorylation | DSGSRRASSIAASRL CCCCHHHHHHHHHHH | 22.07 | 28985074 | |
679 | Phosphorylation | SGSRRASSIAASRLE CCCHHHHHHHHHHHH | 18.43 | 28985074 | |
679 | Ubiquitination | SGSRRASSIAASRLE CCCHHHHHHHHHHHH | 18.43 | 21890473 | |
680 | Ubiquitination | GSRRASSIAASRLEE CCHHHHHHHHHHHHH | 3.25 | - | |
683 | Phosphorylation | RASSIAASRLEEAMS HHHHHHHHHHHHHHH | 28.51 | 23090842 | |
690 | Phosphorylation | SRLEEAMSELTMPSS HHHHHHHHHCCCCHH | 36.18 | 29255136 | |
693 | Phosphorylation | EEAMSELTMPSSVLK HHHHHHCCCCHHHHH | 24.00 | 24292712 | |
696 | Phosphorylation | MSELTMPSSVLKQGP HHHCCCCHHHHHCCH | 23.43 | 29255136 | |
697 | Phosphorylation | SELTMPSSVLKQGPM HHCCCCHHHHHCCHH | 26.12 | 30108239 | |
758 | Ubiquitination | RGRLAEVKGNLEEAK CHHHHHHCCCHHHHH | 33.32 | - | |
765 | Ubiquitination | KGNLEEAKQLYKEAL CCCHHHHHHHHHHHH | 44.08 | 21890473 | |
765 (in isoform 1) | Ubiquitination | - | 44.08 | 21890473 | |
769 | Ubiquitination | EEAKQLYKEALTVNP HHHHHHHHHHHCCCC | 45.14 | - | |
782 | Ubiquitination | NPDGVRIMHSLGLML CCCHHHHHHHHHHHH | 0.92 | - | |
784 | Phosphorylation | DGVRIMHSLGLMLSR CHHHHHHHHHHHHHH | 13.52 | 20068231 | |
793 | Ubiquitination | GLMLSRLGHKSLAQK HHHHHHCCCHHHHHH | 25.68 | - | |
795 | Ubiquitination | MLSRLGHKSLAQKVL HHHHCCCHHHHHHHH | 45.42 | - | |
800 | Ubiquitination | GHKSLAQKVLRDAVE CCHHHHHHHHHHHHH | 37.31 | 2189047 | |
800 (in isoform 1) | Ubiquitination | - | 37.31 | 21890473 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TTC7A_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TTC7A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TTC7A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CAMKV_HUMAN | CAMKV | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
243150 | Gastrointestinal defects and immunodeficiency syndrome (GIDID) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51 AND SER-182, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51 AND SER-647, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51 AND SER-647, AND MASSSPECTROMETRY. |